PGF Veyx Forte 0.250 mg/ml Solution for Injection for Cattle and Pigs

País: Reino Unido

Idioma: inglés

Fuente: VMD (Veterinary Medicines Directorate)

Ingredientes activos:

Cloprostenol

Disponible desde:

Veyx-Pharma GmbH

Código ATC:

QG02AD90

Designación común internacional (DCI):

Cloprostenol

formulario farmacéutico:

Solution for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cattle, Pigs

Área terapéutica:

Prostaglandin

Estado de Autorización:

Authorized

Fecha de autorización:

2012-10-09

Ficha técnica

Revised: November 2023
AN: 01789/2023 & 01790/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
PGF Veyx forte 0.250 mg/ml solution for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml solution for injection contains:
ACTIVE SUBSTANCE:
Cloprostenol
0.250 mg (corresponding to 0.263 mg cloprostenol sodium)
EXCIPIENTS:
Chlorocresol
1.0 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (heifers, cows) and pigs (sows)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Cattle (heifers, cows):
•
To schedule the time of oestrous and ovulation and for cycle
synchronization in animals with an ovulatory cycle when applied during
the diestrus (induction of oestrus in non-detected oestrus,
synchronisation
of oestrus)
•
Treatment of anoestrus and uterine disorders caused by a progesterone-
induced oestrous cycle blockade (induction of oestrous in anoestrus,
endometritis,
pyometra,
corpus
luteal
cysts,
follicular
luteal
cysts,
shortening of the sexual rest period)
•
Induction of abortion up to day 150 of pregnancy
•
Expulsion of mummified foetuses
•
Induction of parturition
Pigs (sows):
•
Induction or synchronisation of farrowing from day 114 of pregnancy
onwards (day 1 of pregnancy is the last day of insemination).
Revised: November 2023
AN: 01789/2023 & 01790/2023
Page 2 of 6
4.3
CONTRAINDICATIONS
▪
Do not use for intravenous administration
▪
Do not use in pregnant animals where the induction of abortion or
parturition is not intended
▪
Do not use in case of spastic diseases of the respiratory tract and
gastrointestinal tract
▪
Do not use in cases of hypersensitivity to the active substance or to
any of
excipients
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN
ANIMALS
To reduce the risk of anaerobic infections care should be take